Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Marin

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Transplantation and Cellular Therapy|December 5, 2022
HLA Factors versus Non-HLA Factors for Haploidentical Donor SelectionRohtesh S Mehta, Kai Cao, Rima M Saliba, et al.
Bone Marrow Transplantation|January 5, 2021
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHDRohtesh S Mehta, Roland Bassett, Gabriela Rondon, et al.
American Journal of Hematology|February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trialIssa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous TransplantIssa F Khouri, Denái R Milton, Alison M Gulbis, et al.
Haematologica|June 30, 2022
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II studyUday R Popat, Borje S Andersson, Roland Bassett, et al.
American Journal of Hematology|February 5, 2024
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II studySairah Ahmed, Qaiser Bashir, Roland L Bassett, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2016
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipientsAla Abudayyeh, Amir Hamdi, Maen Abdelrahim, et al.
Frontiers in Immunology|November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignanciesHarjeet Singh, Samer A Srour, Denái R Milton, et al.
Virchows Archiv : an International Journal of Pathology|February 23, 2024
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agentsMario L Marques-Piubelli, Bijender Kumar, Rafet Basar, et al.
Blood|December 11, 2012
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationshipsJamshid S Khorashad, Todd W Kelley, Philippe Szankasi, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Transplantation and Cellular Therapy|December 5, 2022
HLA Factors versus Non-HLA Factors for Haploidentical Donor SelectionRohtesh S Mehta, Kai Cao, Rima M Saliba, et al.
Bone Marrow Transplantation|January 5, 2021
Randomized phase II trial of extracorporeal phototherapy and steroids vs. steroids alone for newly diagnosed acute GVHDRohtesh S Mehta, Roland Bassett, Gabriela Rondon, et al.
American Journal of Hematology|February 24, 2024
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trialIssa F Khouri, Kamal Alzahrani, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous TransplantIssa F Khouri, Denái R Milton, Alison M Gulbis, et al.
Haematologica|June 30, 2022
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II studyUday R Popat, Borje S Andersson, Roland Bassett, et al.
American Journal of Hematology|February 5, 2024
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II studySairah Ahmed, Qaiser Bashir, Roland L Bassett, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2016
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipientsAla Abudayyeh, Amir Hamdi, Maen Abdelrahim, et al.
Frontiers in Immunology|November 28, 2022
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignanciesHarjeet Singh, Samer A Srour, Denái R Milton, et al.
Virchows Archiv : an International Journal of Pathology|February 23, 2024
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agentsMario L Marques-Piubelli, Bijender Kumar, Rafet Basar, et al.
Blood|December 11, 2012
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationshipsJamshid S Khorashad, Todd W Kelley, Philippe Szankasi, et al.
Pageof 18